Neurotoxicity of FIV and FIV envelope protein in feline cortical cultures

Brain Research

Volumn 816, Issue 2, 1999, Pages 431-437

  Bragg, D Cristopher ^a   Meeker, Rick B ^a   Duff, Barbara A ^a   English, Robert V ^b   Tompkins, Mary B ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Feline immunodeficiency virus; Glutamate; Gp120; Neurotoxicity

Indexed keywords

ENVELOPE PROTEIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; TETRODOTOXIN;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CAT; CELL CULTURE; CELL SWELLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CATS; CELLS, CULTURED; CEREBRAL CORTEX; IMMUNODEFICIENCY VIRUS, FELINE; NEURONS; NEUROTOXINS; VIRAL ENVELOPE PROTEINS; VIRULENCE;

EID: 0033596519     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01177-9     Document Type: Article

References (52)

1. Bagasra O., Lavi E., Bobroski L., Khalili K., Pestaner J.P., Tawadros R., Pomerantz R.J. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS. 10:1996;573-585.
2. Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., Ceccherini-Nelli L., Malvaldi G., Tozzini F. Feline immunodeficiency virus: an interesting model for aids studies and an important cat pathogen. Clinical Microbiology Reviews. 8:1995;87-112.
3. Brenneman D., Westbrook G., Fitgerald S., Ennis D., Elkins K., Ruff M., Pert C. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 335:1988;639-642.
4. Brenneman D.E., Westbrook G.L., Fitzgerald S.P., Ennist D.L., Elkins K.L., Ruff M.R., Pert C.B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 335:1988;639-642.
5. Darko D.F., Mitler M.M., Henriksen S.J. Lentiviral infection, immune response peptides, and sleep. Adv. Neuroimmunol. 5:1995;57-77.
6. Dawson V., Dawson T., Uhl G., Synder S. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. 90:1993;3256-3259.
7. Dean A.F., Montgomery M., Baskerville A., Cook R.W., Cranage M.P., Sharpe S.A., Dennis M.J., Luthert P.J., Hou S.-T., Lantos P.L. Different patterns of neuropathological disease in rhesus monkeys infected by simian immunodeficiency virus, and their relation to the humoral immune response. Neuropathol. Appl. Neurobiol. 19:1993;336-345.
8. Diop A.G., Lesort M., Esclaire F., Sindou P., Couratier P., Hugon J. Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neuroscience Letters. 165:1994;187-190.
9. Dow S.W., Dreitz M.J., Hoover E.A. Feline immunodeficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells. Veterinary Immunology and Immunopathology. 35:1992;23-35.
10. L. Epstein, H. Gendelman, S. Lipton, Human immunodeficiency virus-1 neuropathogenesis, in: J.R. Berger, R.M. Levy (Eds.), AIDS and the Nervous System, Lippincott-Raven, Philadelphia, 1997, pp. 59-75.
11. Everall I., Gray F., Barnes H., Durigon M., Luthert P., Lantos P. Neuronal loss in symptom-free HIV infection. Lancet. 340:1995;1413-1413.
12. Everall I.P., Luthert P.J., Lantos P.L. Neuronal number and volume alterations in the neocortex of HIV infected individuals. J. Neurol. Neurosurg. Psychiatry. 56:1993;481-486.
13. Gardner M.B., Dandekar S. Neurobiology of simian and feline immunodeficiency virus infections. Current Topics in Microbiology and Immunology. 202:1995;135-150. 41.
14. Gelbard H.A., Dzenko K., Diloreto D., Delcerro C., Epstein L.G. Neurotoxic effects of tumor necrosis factor in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 15:1994;418-422.
15. Gelbard H.A., Nottet H.S., Swindells S., Jett M., Dzenko K.A., Genis P., White R., Wang L., Choi Y.B., Zhang D.et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68:1994;4628-4635.
16. Gendelman H.E., Lipton S.A., Tardieu M., Bukrinsky M.I., Nottet H.S. The neuropathogenesis of HIV-1 infection. J. Leukocyte Biol. 56:1994;389-398.
17. Giulian D., Vaca K., Noonan C.A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 250:1990;1593-1596.
18. Giulian D., Yu J., Li X., Tom D., Li J., Wendt E., Lin S.-N., Schwarcz R., Noonan C. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J. Neurosci. 16:1996;3139-3153.
19. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:1995;755-762.
20. D.L. Gruol, N. Yu, K.L. Parsons, J.N. Billaud, J.H. Elder, T.R. Phillips, Neurotoxic effects of feline immunodeficiency virus, FIV-PPR, J. Neurovirol. (1998).
21. Henriksen S.J., Prospero-Garcia O., Phillips T.R., Fox H.S., Bloom F.E., Elder J.H. Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system. Current Topics in Microbiology and Immunology. 202:1995;167-186.
22. Hesselgesser J., Halks-Miller M., DelVecchio V., Peiper S.C., Hoxie J., Kolson D.L., Taub D., Horuk R. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Current Biology. 7:1997;112-121.
23. Heyes M.P., Brew B.J., Martin A., Price R.W., Salazar A.M., Sidtis J.J., Yergey J.A., Mouradian M.M., Sadler A.E., Keilp J.et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:1991;202-209.
24. Hill J.M., Mervis R.F., Avidor R., Moody T.W., Brenneman D.E. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res. 603:1993;222-233.
25. Horuk R., Martin A.W., Wang Z., Schweitzer L., Gerassimides A., Guo H., Lu Z., Hesselgesser J., Perez H.D., Kim J., Parker J., Hadley T.J., Peiper S.C. Expression of chemokine receptors by subsets of neurons in the central nervous system. Journal of Immunology. 158:1997;2882-2890.
26. Koenig S., Gendelman H.E., Orenstein J.M., Dal Canto M.C., Pezeshkpour G.H., Yungbluth M., Janotta F., Aksamit A., Martin M.A., Fauci A.S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 233:1986;1089-1093.
27. Koka P., He K., Zack J.A., Kitchen S., Peacock W., Fried I., Tran T., Yashar S.S., Merrill J.E. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. Journal of Experimental Medicine. 182:1995;941-951.
28. Lipton S. Requirement of macrophages in neuronal injury induced by HIV envelope protein gp120. NeuroReport. 3:1992;913-915.
29. Lipton S., Sucher N., Kaiser P., Dreyer E. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 7:1991;111-118.
30. Lo T.K., Fallert C.J., Piser T.M., Thayer S.A. HIV-1 envelope protein evokes intracellular calcium oscillations in rat hippocampal neurons. Brain Res. 594:1992;189-196.
31. Meeker R.B., English R., Tompkins M. Enhanced excitotoxicity in primary feline neural cultures exposed to feline immunodeficiency virus (FIV). J. Neuro. AIDS. 1:1996;1-27.
32. Meeker R.B., Thiede B.A., Hall C., English R., Tompkins M. Cortical cell loss in asymptomatic cats experimentally infected with feline immunodeficiency virus. AIDS Research and Human Retroviruses. 13:1997;1131-1140.
33. Nath A., Geiger J.D. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Progress in Neurobiology. 54:1998;19-33.
34. Nath A., Padua R.A., Geiger J.D. HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium. Brain Res. 678:1995;200-206.
35. New D.R., Ma M., Epstein L.G., Nath A., Gelbard H.A. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. Journal of Neurovirology. 3:1997;168-173.
36. Opp M.R., Rady P.L., Hughes T.K., Cadet P., Tyring S.K., Smith E.M. Human immunodeficiency virus envelope glycoprotein 120 alters sleep and induces cytokine mRNA in rats. American Journal of Physiology. 270:1996;R963-R970.
37. Phillips T., Prospero-Garcia O., Puaoi D., Lerner D., Fox H., Olmsted R., Bloom F., Heriksen S., Elder J. Neurological abnormalities associated with feline immunodeficiency virus infection. J. Gen. Virol. 75:1994;979-987.
38. Phillips T.R., Prospero-Garcia O., Wheeler D.W., Wagaman P., Lerner D.L., Fox H.S., Whalen L.R., Bloom F.E., Elder J.H., Henricksen S.J. Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J. Neurovirol. 2:1996;388-396.
39. Phillips T.R., Talbott R., Lamont C., Muir S., Lovelace K., Elder J.H. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64:1990;4605-4613.
40. Power C., McArthur J.C., Johnson R.T., Griffin D.E., Glass J.D., Perryman S., Chesebro B. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J. Virol. 68:1994;4643-4649.
41. Prospero-Garcia O., Herold N., Phillips T., Elder J., Bloom F., Henriksen S. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc. Natl. Acad. Sci. 91:1994;12947-12951.
42. Prospero-Garcia O., Herold N., Waters A., Phillips T., Elder J., Henriksen S. Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats. Brain Res. 659:1994;254-258.
43. Pulliam L., Herndier B.G., Tang N.M., McGrath M.S. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87:1991;503-512.
44. Rottman J.B., Ganley K.P., Williams K., Wu L., Mackay C.R., Ringler D.J. Cellular localization of the chemokine receptor CCR5, correlation to cellular targets of HIV-1 infection. American Journal of Pathology. 151:1997;1341-1351.
45. Sopper S., Demuth M., Stahl-Hennig C., Hunsmann G., Plesker R., Coulibaly C., Czub S., Ceska M., Koutsilieri E., Riederer P., Brinkmann R., Katz M., Ter, Meulen V. The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology. 220:1996;320-329.
46. Sparger E.E., Beebe A.M., Dua N., Himathongkam S., Elder J.H., Torten M., Higgins J. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. Virology. 205:1994;546-553.
47. Toggas S.M., Masliah E., Rockenstein E.M., Rall G.F., Abraham C.R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367:1994;188-193.
48. Tymianski M., Charlton M.P., Carlen P.L., Tator C.H. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J. Neurosci. 13:1993;2085-2104.
49. Wiley C., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., Hansen L., Terry R. Neocortical damage during HIV infection. Ann. Neurol. 29:1991;651-657.
50. Wiley C.A., Schrier R.D., Nelson J.A., Lampert P.W., Oldstone M.B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA. 83:1986;7089-7093.
51. Yeung M.C., Pulliam L., Lau A.S. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS. 9:1995;137-143.
52. Yu N., Billaud J.N., Phillips T.R. Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases. Proc. Natl. Acad. Sci. USA. 95:1998;2624-2629.